October 04, 2024

Omalizumab Boosts Tolerance to Food Allergens: Study

In a phase 3 trial, 67% of children treated with omalizumab tolerated 600 mg of peanut protein, a dramatic increase over just 7% with placebo, highlighting omalizumab’s potential in managing pediatric food allergies.

Conexiant

October 02, 2024

Breast is Best? New Research Maps the World's Milk Defenses

New research compares human milk antibody levels against infectious pathogens across different income countries, revealing important insights for infant health.

Conexiant

September 24, 2024

Pediatric Wards: Idaho Bursting, Alaska Empty

From overflowing cribs to empty pediatric wings, new data reveals a 133.3% difference in children's hospital bed occupancy rates between the most and least crowded states.

Conexiant

September 20, 2024

FDA Greenlights First DIY Flu Vaccine

The FDA's approval for self-administration could change how the U.S. addresses 9.3M to 41M flu cases annually.

Conexiant

September 18, 2024

Tracheostomy Tubes Recalled Over Manufacturing Defect

The FDA has classified the recall of certain tubes as the most serious type, which could cause severe injury or death. Specific lots of the tubes sold under the Bivona brand for neonatal or pediatric and adult patients are being recalled due to a manufacturing defect.

Reuters

September 17, 2024

Can Saline Drops Cut Kids' Colds Short?

Hypertonic saline nasal drops shortened children's colds by 2 days and reduced household transmission by 15%, according to a randomized trial.

Conexiant

September 10, 2024

EASD: Diabetes-Asthma May Share Bidirectional Link

Patients with type 2 diabetes may face an 83% higher risk of developing asthma, while patients with asthma are 28% more likely to develop diabetes, revealing a bidirectional relationship.

Conexiant

September 09, 2024

Boys' Cortisol Levels Influenced by Behavior and Noise, Study Finds

A study in Hormones and Behavior delves into the impact of behavioral problems, environmental noise, maternal stress, and air pollution on hair cortisol levels in 11-year-old children.

Conexiant

April 29, 2024

Nasal Neomycin May Offer Virus Protection 

A study funded by the Melinda and Bill Gates Foundation demonstrates the potential of intranasal neomycin to elicit broad-spectrum antiviral immunity in the upper respiratory tract, providing significant protection against upper respiratory infections in animal models and showing promising results in a pilot human study.

Conexiant